Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of MOMA-341 as Monotherapy or Combination Therapy in Participants With Advanced or Metastatic Solid Tumors

NCT06974110 is registered in ClinicalTrials.gov with MOMA Therapeutics as lead sponsor.

NCT NCT06974110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06974110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of MOMA-341 as Monotherapy or Combination Therapy in Participants With Advanced or Metastatic Solid Tumors
Lead sponsor
MOMA Therapeutics
Phase
Phase 1
Overall status
Recruiting
Start date
July 16, 2025
Completion date
May 31, 2028
Enrollment
132 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor, colorectal cancer, dmmr cancer, endometrial cancer, gastric cancer, metastatic solid tumor, msi-h cancer